Abstract. 6-(methylsulfinyl)hexyl isothiocyanate (6-MITC) is a bioactive compound extracted from a typical Japanese spice, wasabi (Wasabia japonica (Miq.) Matsumura). In the present study, we found that 6-MITC suppressed the expression of cyclooxygenase-2 (COX-2) induced by lipopolysaccharide (LPS), interferon-Á (IFN-Á), but did not suppress that induced by 12-O-tetradecanoylphorbol-13-acetate (TPA), in murine macrophage RAW264. Molecular mechanisms were investigated by targeting the transcriptional factors including activator protein-1 (AP-1), CCAAT/enhancer-binding protein ‰ (C/EBP‰), CRE-binding protein (CREB) and nuclear factor κB (NF-κB), which bind to the core element of COX-2 promoter. LPS induced activation of all of these factors and 6-MITC suppressed LPS-induced activation of AP-1, C/EBP‰, CREB, but not NF-κB. IFN-Á did not induce any activation of these factors, but 6-MITC suppressed IFN-Á-induced COX-2 expression, suggesting that the upstream region of the core element is linked for this suppression. Finally, TPA stimulated the activation of CREB and AP-1, but 6-MITC did not block TPA-induced COX-2 expression. These results suggest that LPS, IFN-Á and TPA regulate COX-2 expression through different mechanisms, and 6-MITC acts as a potent inhibitor of COX-2 expression induced by LPS or IFN-Á.
Introduction
Numerous studies have demonstrated that high intake of cruciferous vegetables such as broccoli, watercress, cabbage, and cauliflower, can prevent cancer (1) . The bioactive compounds involved in these vegetables are isothiocyanates (ITCs), which have been reported to have cancer-preventive effect in the carcinogenesis of lung, breast and colon (2). 6-(methylsulfinyl) hexyl isothiocyanate (6-MITC) is an ITC, present as a major allyl isothiocyanate in a typical Japanese spice, wasabi (Wasabia japonica (Miq.) Matsumura). Oral administration of 6-MITC showed the inhibitory effects on mouse skin tumor induced by 9,10-dimethyl-1,2-benzanthracene as an initiator and 12-O-tetradecanoylphorbol-13-acetate (TPA) as a promoter (3) , and on mouse lung tumor induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (4). 6-MITC also has been demonstrated to specifically suppress cell proliferation of breast cancer and melanoma cell lines (5) . These results suggest that 6-MITC is a potent chemopreventive compound.
Cyclooxygenase (COX-2) is an enzyme catalyzing the conversion of arachidonic acid to prostaglandins. There are two isoforms of COX, designated COX-1 and COX-2. COX-1 is constitutively expressed in most tissues to maintain normal physiological functions (6) . In contrast, COX-2 is undetectable or present at very low levels under basal conditions, but is rapidly induced by inflammatory stimuli, cytokines, growth factors, tumor promoters, and carcinogens (7, 8) . Several lines of evidence suggest that COX-2 plays an important role in the process of carcinogenesis because COX-2 is overexpressed in a variety of transformed cells and tumors (9, 10) . Enhanced induction of COX-2 promotes the growth of malignant cells by increasing cell proliferation (11) , promoting angiogenesis (12) , and inhibiting immune surveillance (13) and apoptosis (14) . Various chemopreventive strategies have focused on the identification of COX-2 inhibitors because the targeted inhibition of COX-2 is an effective approach for suppressing inflammation and carcinogenesis.
Accumulated data have indicated that there are three cisacting elements including nuclear factor κB (NF-κB), CCAAT/ enhancer-binding protein (C/EBP) and cAMP-responsive element (CRE) present in the promoter (15) . The tran-scriptional factors such as NF-κB, C/EBPs, CRE binding protein (CREB) and activator protein-1 (AP-1) bind to these cis-acting elements and transactivate COX-2 gene expression. Various different inflammatory stimuli have been reported to induce COX-2 gene transcription (7, 8) . However, the precise mechanisms underlying COX-2 gene expression triggered by these stimuli have not been fully elucidated.
In the present study, we investigated the effect of 6-MITC on COX-2 expression activated by LPS, INF-Á, and TPA in murine macrophage RAW264 cells. Our study revealed that LPS, IFN-Á and TPA induced COX-2 expression through different pathways, and 6-MITC acted as a potent inhibitor for intervening LPS-and IFN-Á-activated COX-2 expression.
Materials and methods
Materials and cell culture. 6-MITC purified by reverse-phase HPLC to >99% were obtained from Hakucho Pharmaceutical Co., Ltd (Japan). 6-MITC was dissolved in dimethyl sulfoxide (DMSO, final concentration was 0.2%). Antibodies against phospho-CREB, phospho-c-Jun, CREB, c-Jun and IκB-· were purchased from Cell Signaling Technology (Beverly, MA). Antibodies against COX-2, COX-1, C/EBPß, C/EBP‰, p65 and ·-tubulin were from Santa Cruz Biotechnology, Inc. Western blot analysis. Western blot assay was performed as described previously (16) . In brief, RAW264 (1x10 6 cells) were pre-cultured in a 6-cm dish for 24 h, and then starved by being cultured in serum-free medium for another 2.5 h to eliminate the influence of FBS. The cells were treated with or without 6-MITC for 30 min before exposure to LPS, IFN-Á, TPA, interleukin-ß (IL-ß), tumor necrosis factor-· (TNF-·), or H 2 O 2 for different times. The harvested cells were lysed and the supernatants were boiled for 5 min. Protein concentration was determined using dye-binding protein assay kit (Bio-Rad Hercules, CA) according to the manufacturer's manual. Equal amounts of lysate protein (~40 μg) were run on 10% SDS-PAGE and electrophoretically transferred to PVDF membrane (Amershan Pharmacia Biotech, Little Chalfont, UK). After Western blotting, the membrane was incubated with specific primary antibody overnight at 4˚C, and further incubated for 1 h with HRP-conjugated secondary antibody. Bound antibodies were detected by ECL system with a Lumi Vision PRO machine (Taitec Co., Japan). The relative amount of proteins associated with each specific antibody was quantified using the Lumi Vision Imager software (Taitec Co.).
Plasmids. The COX-2 promoter-luciferase deletion constructs (-1432/+59, -327/+59) were generous gifts of Dr Hiroyasu Inoue (Nara Women's University, Nara, Japan) and have been described previously (17) (18) (19) .
Transient transfection assay. Transient transfection was performed according to the modified method as described previously (20) . RAW264 cells (1x10 5 ) were plated into each well of 12-well plates, and cultured for 24 h. The cells were then co-transfected with 0.5 μg COX-2 promoter-luciferase plasmids and 0.12 μg CMV-ß-galactosidase plasmids using Lipofectamine 2000. After 5 h of incubation, the medium was replaced and cultured for another 20.5 h. The cells were treated with or without 6-MITC for 30 min before exposure to 40 ng/ml LPS, IFN-Á, or TPA for 6 h. The activities of luciferase and ß-galactosidase in cell lysate were measured with a luminometer (Berthold) according to the supplier's recommendations. Luciferase activity is normalized to transfection efficiency monitored by ß-galactosidase expression, and COX-2 transcription activity was expressed as fold induction relative to the control cells without LPS, IFN-Á, or TPA treatment.
Nuclear extracts. Nuclear extracts were prepared using the nuclear extract kit from Active Motif (Carlsbad, CA). Briefly, RAW264 cells (3x10 6 ) were pre-cultured in a 10-cm dish for 24 h, and then starved by being cultured in serum-free medium for another 2.5 h to eliminate the influence of FBS. The cells were treated with or without 6-MITC for 30 min before exposure to 40 ng/ml LPS, IFN-Á, or TPA. The cell pellet was suspended in 1 x hypotonic buffer supplemented with complete protease inhibitor cocktail, incubated for 15 min at 4˚C, voltexed with detergents and centrifuged briefly. The nuclear pellet was washed twice with the cytoplasmic buffer followed by resuspension in the lysis buffer supplemented with 1 mM DTT and protease inhibitors. The suspension was incubated on a rocking platform at 4˚C for 30 min. The suspension was then voltexed briefly and centrifuged for 10 min at 14,000 x g at 4˚C. The supernatant (nuclear fraction) was collected, and nuclear extracts were stored at -80˚C until Western blot analysis.
Statistical analysis. Difference between the treated and the control was analyzed by Student's t-test. A probability of P<0.05 was considered significant. 12 μg CMV-ß-galactosidase plasmid. After 5 h of incubation, the medium was replaced with complete medium and cultured for another 20.5 h. The cells were then treated with or without 6-MITC for 30 min before they were exposed to 40 ng/ml LPS, IFN-Á and TPA for 6 h. The luciferase activity values were normalized to transfection efficiency monitored by ß-galactosidase expression, and COX-2 promoter activity was expressed as fold induction to control. Each value represents the mean ± SD of three to four separate experiments. * P<0.05 versus control.
Results
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COX-2 expression. However, 6-MITC did not suppress TPAinduced COX-2. The amount of COX-1, which was constitutive protein, remained uncharged. To further examine the inhibitory effects of 6-MITC on COX-2 expression induced by LPS or IFN-Á, the cells were incubated with various concentrations of 6-MITC before the treatment with LPS or IFN-Á. Fig. 2B shows that 6-MITC inhibited COX-2 expression induced by LPS or IFN-Á in a dose-dependent manner. Our previous results have shown that the concentration range of 6-MITC used in these experiments had no significant effect on the cellular viability as measured by MTT assay (data not shown) (25) . Thus, the inhibitory actions of 6-MITC on COX-2 expression were not caused by its toxicity.
Different effects of 6-MITC on LPS-, IFN-Á-or TPA-induced COX-2 promoter activity.
The core element (-327/-52) in COX-2 promoter contains three cis-acting elements including NF-κB, C/EBP and CRE sites, which are involved in the regulation of COX-2 gene expression (15) . To investigate whether the inhibition of COX-2 expression by 6-MITC is mediated through the core element, transient transfections were performed using full (-1432/+59) and core (-327/+59) COX-2 promoter-luciferase constructs (Fig. 3A) . As shown in Fig. 3B, 1 ) LPS induced COX-2 promoter activity in both -1432/+59 and -327/+59 constructs, and 6-MITC reduced them to control level. 2) IFN-Á induced COX-2 promoter activity of -1432/+59 construct, which was suppressed by 6-MITC. IFN-Á did not induce the promoter activity of -327/+59 construct. 3) TPA also induced the COX-2 promoter activity in both -1432/+59 and -327/+59, but 6-MITC did not block the transcriptional activity. These results suggest that the core element is required for LPS-and TPA-induced COX-2 gene expression, and 6-MITC might block LPS-induced COX-2 expression by suppressing the core element. On the other hand, the upstream region of the core element may respond to the IFN-Á-induced COX-2 expression, and 6-MITC may block COX-2 expression through the upstream region.
Effects of 6-MITC on the transcriptional factors regulating COX-2 expression.
Transcription factors including CREB, AP-1, C/EBP and NF-κB can regulate COX-2 transcription by binding the core elements in COX-2 promoter (15, 18, 26) . To elucidate the effects of 6-MITC on these transcriptional factors, we pretreated RAW264 cells with 6-MITC for 30 min before exposure to LPS, IFN-Á, or TPA, and then examined the activation of these transcription factors by Western blot analysis.
As shown in Fig. 4A , LPS and TPA strongly induced the phosphorylation of CREB and c-Jun, which is a key component of AP-1 in c-Jun/c-Fos heterodimer form. 6-MITC blocked the phosphorylation of CREB and c-Jun induced by LPS, but not TPA. In contrast, IFN-Á did not induce phosphorylation of CREB and c-Jun.
LPS also markedly induced expression and nuclear translocation of C/EBP‰, which were blocked by 6-MITC (Fig. 4B) . However, IFN-Á and TPA did not induce C/EBP‰ at either whole or nuclear fraction. The C/EBPß levels at either whole or nuclear were not affected by three inducers and 6-MITC. These results suggest that 6-MITC suppressed LPS-activated expression and subsequent nuclear translocation of C/EBP‰ leading to COX-2 expression. In contrast, C/EBP‰ was not involved in IFN-Á-and TPA-induced COX-2 expression.
NF-κB is also known as a critical factor for COX-2 expression induced by LPS or proinflammatory cytokines (17, 27) . NF-κB is inactivated in the cytosol by binding to IκB, and becomes active through translocation to the nucleus preceded by LPS-induced proteolytic degradation of IκB (28) . To determine whether 6-MITC inhibit degradation of IκB, the level of IκB-· protein was assessed in the treated RAW264 cells. As shown in Fig. 4C , LPS reduced IκB-· protein, and stimulated nuclear translocation of p65, a major component of NF-κB, into nucleus. However, 6-MITC did not prevent the degradation of IκB-· and nuclear translocation of p65. On the other hand, IFN-Á and TPA had no influence on IκB-· degradation and nuclear translocation of p65. These data suggest that the inhibitory effect of 6-MITC on LPS-induced COX-2 expression is not mediated through the suppression of NF-κB activation, and IFN-Á-and TPA-induced COX-2 expression in RAW264 cells is not mediated by NF-κB activation.
Discussion
Multiple lines of evidence suggest that COX-2 has a critical role in inflammation and carcinogenesis. Thus, the targeted inhibition of COX-2 by chemopreventive agents is a promising approach to prevent inflammation and cancer. In the present study, 6-MITC, a major compound in wasabi, strongly blocked the expression of COX-2 induced by LPS or IFN-Á, but not TPA, suggesting that LPS, IFN-Á and TPA might induce COX-2 expression through distinct pathways in mouse macrophage cells.
The inductive effects of LPS on COX-2 induction are mediated by transcriptional factors including AP-1, C/EBP and NF-κB, which bind to the core elements of COX-2 (15). Moreover, there is redundancy in the three cis-acting elements, and two of these cis-acting elements are at least recruited to achieve maximal transcription of COX-2 gene in mouse macrophage RAW264.7 cells (29) . In the present study, our data indicated that the 6-MITC blocked LPS-induced COX-2 expression by suppressing the activation of CREB, AP-1 and C/EBP‰, which lead to the binding to the core element of COX-2 gene.
IFN-Á is a potent inducer of inflammatory responses (30) . The present study demonstrated that IFN-Á induced COX-2 expression, which was suppressed by 6-MITC (Fig. 2) . IFN-Á did not activate the transcriptional factors including NF-κB, C/EBP, CREB and AP-1, which bind to the core element of COX-2 promoter (Fig. 4) . Blanco et al reported that a member of the IRF family, IRF-1, regulates IFN-Á-induced COX-2 gene expression through two ISRE sites in mouse peritoneal macrophages (31) . ISRE II sites are located in the -1354/-1345 region of COX-2 promoter, and are efficiently bound with IRF-1 and IRF-2. In this study, transient transfections using COX-2-luciferase constructs indicated that IFN-Á increased COX-2 gene expression through the region between -1432 and -327 in COX-2 promoter (Fig. 3) . Therefore, the inhibitory action of 6-MITC on IFN-Á-induced COX-2 expression is probably associated with IRF-1/2-ISRE II pathway, which is worthy of further study.
TPA has been shown to upregulate COX-2 expression in several cell lines. In the present study, we found that TPA activated CREB and AP-1, and induced COX-2 expression. However, 6-MITC could not block them. On the other hand, 6-MITC strongly blocked LPS-induced activation of CREB and AP-1. These results indicate that the signaling pathway leading to the activation of CREB and AP-1 by TPA is different from that induced by LPS. It has been reported that TPA acted as an activator of protein kinase C in several cell lines including RAW264.7 cells (32) (33) (34) , and TPA-induced PKC activation is strongly linked with COX-2 induction. However, further study is needed to clarify this.
In summary, we report for the first time that 6-MITC suppressed COX-2 expression induced by LPS or IFN-Á, but not TPA, in murine macrophages. Molecular analysis revealed that LPS, IFN-Á and TPA might induce COX-2 expression through different signaling pathways. These findings are very helpful to further understand the property of 6-MITC as an anti-inflammatory and anti-cancer agent.
